Publication Name	World Journal of Radiology
Manuscript ID	22452
Country	Canada

Received	2015-08-29 16:47
Peer-Review Started	2015-09-06 16:47
To Make the First Decision	2015-10-27 11:22
Return for Revision	2015-11-04 20:16
Revised	2015-11-17 08:02
Second Decision	2016-01-14 17:51
Accepted by Journal Editor-in-Chief	2016-01-14 22:08
Accepted by Company Editor-in-Chief	2016-01-22 16:18
Articles in Press	2016-01-22 16:19
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-03-31 12:16
Publish the Manuscript Online	2016-04-19 16:30

ISSN	1949-8470 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Clinical Trials Study
Article Title	Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance
Manuscript Source	Invited Manuscript
All Author List	Larissa J Vos, Michele Janoski, Keith Wachowicz, Atiyah Yahya, Oleksandr Boychak, John Amanie, Nadeem Pervez, Matthew B Parliament, Edith Pituskin, B Gino Fallone and Nawaid Usmani
Funding Agency and Grant Number	Funding Agency Grant Number IGAR Initiative and the Clinical Trials Unit at the Cross Cancer Institute, which is supported in part by the Alberta Cancer Foundation
Corresponding Author	Nawaid Usmani, MD, Assistant Professor, Department of Oncology, Cross Cancer Institute, University of Alberta, 11560 University Avenue NW, Edmonton, Alberta T6G 1Z2, Canada. nawaid.usmani@albertahealthservices.ca
Key Words	Active surveillance; Treatment triaging; Magnetic resonance imaging; Indolent disease; Prostate cancer
Core Tip	Multiparametric magnetic resonance imaging (mpMRI) has the potential to distinguish more aggressive prostate cancer even when indolent prostate cancer is the biopsy diagnosis. Addition of mpMRI to active surveillance protocols would benefit decision making.
Publish Date	2016-04-19 16:30
Citation	Vos LJ, Janoski M, Wachowicz K, Yahya A, Boychak O, Amanie J, Pervez N, Parliament MB, Pituskin E, Fallone BG, Usmani N. Role of serial multiparametric magnetic resonance imaging in prostate cancer active surveillance. World J Radiol 2016; 8(4): 410-418
URL	http://www.wjgnet.com/1949-8470/full/v8/i4/410.htm
DOI	http://dx.doi.org/10.4329/wjr.v8.i4.410

Full Article (PDF)	WJR-8-410.pdf
Full Article (Word)	WJR-8-410.doc
Manuscript File	22452-Review.docx
Answering Reviewers	22452-Answering reviewers.pdf
Audio Core Tip	22452-Audio core tip.mp3
Biostatistics Review Certificate	22452-Biostatistics statement.pdf
Clinical Trial Registration Statement	22452-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	22452-Conflict-of-interest statement.pdf
Copyright License Agreement	22452-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	22452-Clinical trial registration statement.pdf
Institutional Review Board Approval Form or Document	22452-Institutional review board statement.pdf
Peer-review Report	22452-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	22452-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	22452-Scientific misconduct check.pdf
Scientific Editor Work List	22452-Scientific editor work list.pdf